X4 Pharmaceuticals Is A Clinical Biopharmaceutical Company Based In Bostonmassachusettswith A Research Center In Viennaaustriathe Company Focuses On Developing And Commercializing Therapies For Rare Immune System Disordersx4 Aims To Improve Patient Outcomes Through Innovative Treatmentsparticularly Those Targeting Cxcr4 Pathway Dysregulation The Company S Flagship Productxolremdia Mavorixafor Is An Fda Approved Therapy For Whim Syndromea Rare Genetic Immunodeficiency Disordermavorixafor Acts As A Cxcr4 Antagonist To Enhance Immune Cell Mobilizationx4 Is Also Advancing Mavorixafor For Additional Rare Diseasesincluding Chronic Neutropenic Disorderswith Plans For A Global Phase 3 Trial X4 Pharmaceuticals Is Dedicated To Addressing Unmet Medical Needs In Patients With Rare Immune Deficienciesthe Company Combines Clinical Development With Commercialization Expertise To Expand Therapeutic Applications And Support Global Clinical Execution
No conferences found for this company.
| Company Name | X4 Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
